FDA Inspection
Sato Pharmaceutical Co., Ltd.Sato Pharmaceutical Co., Ltd. – FDA Inspection, Jul 3, 2018
Record Details
This FDA Inspection record concerns Sato Pharmaceutical Co., Ltd., with an inspection on July 3, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9a4b8420-d982-428c-88b5-2785907b264c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1064716
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Sato Pharmaceutical Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| November 7, 2019 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| October 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2012 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Sato Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.